This page shows you your search results in order of date. This is page number 3.
Order by Relevance | Date
Total 4719 results found since Jan 2013.
Risk factors of suicidal spectrum behaviors in adults and adolescents with attention-deficit / hyperactivity disorder - a systematic review - Austgulen A, Skram NKG, Haavik J, Lundervold AJ.
INTRODUCTION: Adolescents and adults with attention-deficit/hyperactivity disorder (ADHD) are at increased risk of suicidal spectrum behaviors (SSBs). However, there is limited knowledge about risk factors triggering SSBs in this group of people. O...
Source: SafetyLit - August 26, 2023 Category: International Medicine & Public Health Tags: Research Methods, Surveillance and Codes, Models Source Type: news
La FDA informa cambios permanentes en el color de la piel relacionados con el uso del parche Daytrana (sistema transd érmico de metilfenidato) para el tratamiento del ADHD
[06-24-2015] La Administraci ón de Alimentos y Medicamentos (FDA) de los Estados Unidos advierte que el uso del parche Daytrana (sistema transdérmico de metilfenidato) para el tratamiento del Trastorno por Déficit de Atención e Hiperactividad (ADHD, por sus siglas en inglés) puede causar pérdida perm
Source: FDA Center for Drug Evaluation and Research - What's New - August 25, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
6 Red Flags About the Mental-Health Content You ’ re Being Bombarded With on Social Media
The classic vision of therapy revolved around a person on a couch, supine, tapping into their deepest and darkest hopes and fears. A modern-day remix might look like this: a person still on a couch, but at home, scrolling through a constantly refreshing selection of mental-health content on social-media platforms like TikTok and Instagram.
Though it may feel therapeutic, experts advise proceeding with caution. As an increasing number of psychologists step into the role of mental-health influencer, opening the door to fame and financial incentives, their posts—on attachment styles or unresolved trauma or whatever e...
Source: TIME: Health - August 24, 2023 Category: Consumer Health News Authors: Angela Haupt Tags: Uncategorized healthscienceclimate Source Type: news
Treating and Dealing with ADHD
Studies show that the number of children diagnosed with attention-deficit/hyperactivity disorder (ADHD) continues to rise. The FDA has approved two types of medications – stimulants and non-stimulants – to help reduce the symptoms of ADHD and improve functioning in children as young as age 6.
Source: FDA Consumer Health Information Updates - August 23, 2023 Category: Consumer Health News Authors: FDA Source Type: news
Understanding the causal relationships of attention-deficit/hyperactivity disorder with mental disorders and suicide attempt: a network Mendelian randomisation study - Meisinger C, Freuer D.
BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) is a lifespan neurodevelopmental condition resulting from complex interactions between genetic and environmental risk factors. There is evidence that ADHD is associated with other mental disorders...
Source: SafetyLit - August 23, 2023 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Anxiety and somatic symptoms in children and adolescents diagnosed with attention-deficit hyperactivity disorder - Okyar E, Bozatl ı L, Görker I, Okyar S.
In this study, it was...
Source: SafetyLit - August 21, 2023 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Cingulate has $300,000 in cash as it works to develop ADHD drug
Kansas City-Kansas-based Cingulate Inc. has only $300,000 in cash, it said it its most recent financial report. It's working on drug to treat ADHD but still is seeking regulatory approval.
Source: bizjournals.com Health Care:Biotechnology headlines - August 17, 2023 Category: Biotechnology Authors: Ellen Cagle Source Type: news
Suicides Hit Record High; Research Death Investigation; $43M ADHD Settlement
(MedPage Today) -- The U.S. suicide rate reached an all-time high during 2022, CDC data show. (Reuters)
In a randomized trial, more patients on oral antidepressants who took a single intravenous dose of esketamine had at least a 50% reduction...
Source: MedPage Today Psychiatry - August 16, 2023 Category: Psychiatry Source Type: news
ADHD Medication Shortage Continues as the School Year Begins
Parents and doctors say that drug shortages are leading to declines in learning and self-esteem.
Source: NYT Health - August 15, 2023 Category: Consumer Health News Authors: Christina Caron Tags: Drugs (Pharmaceuticals) Shortages Attention Deficit Hyperactivity Disorder Adderall (Drug) Concerta Children and Childhood Education (K-12) Ritalin (Drug) Source Type: news
Akili announces 27% growth of EndeavorRx prescriptions in Q2
The company also announced its intentions to seek FDA approval for EndeavorOTC, its over-the-counter product for adults with ADHD.
Source: mobihealthnews - August 14, 2023 Category: Information Technology Source Type: news
Does anxiety symptomatology affect bullying behavior in children and adolescents with ADHD? - Pityaratstian N, Prasartpornsirichoke J.
Anxiety disorders are common comorbidities in children and adolescents with attention-deficit/hyperactivity disorder (ADHD) who are also at a high risk of bullying behavior. However, little is known about the roles of anxiety symptomatology in the relation...
Source: SafetyLit - August 14, 2023 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Why Everyone ’ s Worried About Their Attention Span —and How to Improve Yours
Seemingly everyone is concerned about concentration these days. Margaret Sibley, a professor of psychiatry and behavioral sciences at the University of Washington School of Medicine, specializes in working with adolescents and adults who have attention-deficit hyperactivity disorder (ADHD). But recently, Sibley says, she and her colleagues have been “inundated” with clients who don’t actually have ADHD—they’re just worried they do.
It’s hard to blame them for worrying. ADHD diagnostic rates are on the rise in the U.S. and posts on TikTok and other social media platforms have convinced...
Source: TIME: Health - August 10, 2023 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthscienceclimate Source Type: news
' Brain Zap ' Therapy Shows Promise in Quieting Childhood ADHD Without Meds
MONDAY, Aug. 7, 2023 -- A new brain-zapping technology may help ease the symptoms of attention deficit hyperactivity disorder (ADHD) in children without some of the side effects stimulant medications can cause, a small, preliminary study...
Source: Drugs.com - Daily MedNews - August 7, 2023 Category: General Medicine Source Type: news
Confusion, COVID-era stress, and cyber hypochondria: Why more adults than ever are seeking ADHD medications
As a woman in my 30s who was constantly typing “ADHD” into my computer, something interesting happened to me in 2021. I started receiving a wave of advertisements beckoning me to get online help for ADHD, or attention-deficit/hyperactivity disorder. One was a free, one-minute assessment to find…#cdc #diagnostic #tiktok #monthslong #conversation
Source: Reuters: Health - August 6, 2023 Category: Consumer Health News Source Type: news
Africa: More Adults Than Ever Have Been Seeking ADHD Medications - an Expert Explains What Could Be Driving Trend
[The Conversation Africa] As a woman in my 30s who was constantly typing "ADHD" into my computer, something interesting happened to me in 2021. I started receiving a wave of advertisements beckoning me to get online help for ADHD, or attention-deficit/hyperactivity disorder. One was a free, one-minute assessment to find out if I had the disorder, another an offer for a digital game that could help "rewire" my brain. Yet another ad asked me if I was "delivering" but still not moving up at work.
Source: AllAfrica News: Health and Medicine - August 5, 2023 Category: African Health Tags: Africa Health and Medicine Sustainable Development Source Type: news
